Valued at USD 1061.49 million in 2024, the global critical care antiarrhythmic drugs market is witnessing significant growth due to the rising demand for advanced healthcare facilities. Forecasted to grow at a CAGR of 5.6% from 2025 to 2034, the market is expected to reach USD 1733.37 billion by 2034, highlighting a surge in demand for effective cardiac care solutions. https://www.expertmarketresearch.com/reports/critical-care-antiarrhythmic-drugs-market